2. AlphaBioCom
is the scientific communication powerhouse
that delivers your most precious assets
with precision, integrity, and passion
Confidential – Not for Distribution
3. Inside AlphaBioCom
• Global capability
• US and UK facilities
• Strength in experience
• Exclusively in-house team
All have at least 4 years
experience
All have PhDs
Full service
• We create, refine and communicate
value for your assets
Confidential – Not for Distribution
5. Experience Across the Product Life
Experience into our 7th Year
Cycle
Phase I Phase II Phase III Product Launch Phase IV
• ORALGAM • ORALGAM • CERVISTA • ADIANA • AVODART
• ACHN-490 • ACHN-490 • CERVARIX • NOVASURE • ADIANA
• ACHN-750 • MENHIBRIX • ULORIC • CERVISTA • BACTROBAN
• ACHN ESA • Nano Assets • LA HPV TEST • CERVARIX • NOVASURE
• Nano assets • MENHIBRIX • ULORIC • CERVISTA
• MONOPREP • HAVRIX • CERVARIX
• RESLIZUMAB • PEDIARIX • FLUVIRIN
• IXIARO • TWINRIX • PEDIARIX
• CERVISTA • IXIARO
• OPTAFLU • TWINRIX
• FLUAD • HAVRIX
• AVODART • NAPROXEN
• DICLOFENAC
• INDOCIN
• ULORIC
• RYTHMOL SR
• ALTABAX
Confidential – Not for Distribution • LOVAZA
6. Scientific Communication Service
Scientific communication planning
Scientific communication development
and execution
Thought Leader identification and
engagement
Confidential – Not for Distribution
7. Scientific communication planning?
• Systematic approach to
ensuring that you reach
your audience with the
right data, information at
the right time with the
right frequency to create a
change in understanding
and/or awareness
– AlphaBioCom
9. Objectives Strategy
Measurement Audience
Objectives Execution Messages
Channels
• Visualize, characterize and state the shift
that you aim to create
Awareness Beliefs Knowledge
10. Objectives Strategy
Measurement Audience
Strategy Execution Messages
Channels
• Intelligent Approach
– Understanding and managing Issues and
Objectives
• Driven by advanced SWOT analysis
• Affirmative issues to assert advantages
• Barriers and disadvantages to weigh and
balance
– Route to success
• Clear defined roadmap to achieve goals
11. Objectives Strategy
Measurement Audience
Audience Execution Messages
Channels
Who do we need How do we define
to communicate and describe
with? them?
How will we know
How do we
we have
communicate
communicated
with them?
effectively?
12. Objectives Strategy
Measurement Audience
Scientific Message Execution Messages
Channels
• Core communication
Tier1 points
• Primary scientific
evidence
• Evidence based
Tier 2 medicine
• Health Economics and
Outcomes Research
• Benefits and attributes
Tier 3 from literature.
• Reviews and supporting
clinical trials
13. Objectives Strategy
Measurement Audience
Scientific Channel Considerations
Execution Messages
Channels
Interactive
Journals Congresses
tools
Impact
Time On-Line Journals
Specialty
Web based
Audience interactive
publications
Time
Interruptive media
Acceptance Company Apps
Acceptance
14. Objectives Strategy
Measurement Audience
Execution Execution Messages
Channels
Situation analysis
Delve into science
Identify plan framework
Research authors
Populate content and finalize plan
Execute deliverables in line with plan framework
Review and refine
15. Objectives Strategy
Measurement Audience
Precision Processes Execution Messages
Channels
• Strict adherence to policies
• Clear defined training and QA procedures
• Proven development processes
– Abstracts
– Posters
– Oral presentations
– Manuscripts
• Data Management and Integrity
– Communications trail
– Audited processes
• Precise project reporting
• How do you manage these processes?
16. Objectives Strategy
Measurement Audience
Planning & Measurement Execution Messages
Channels
What When How
• results • cyclical • set and
versus • before measure key
objectives • during performance
• milestones indicators
• after
versus plans
17. Objectives Strategy
Measurement Audience
Planning & Measurement Execution Messages
Channels
ID Task Name Duration Start Finish Jan Feb March April May June July
1 Program 106 days Wed Jan 28, ‘09 Wed Jan 24, ‘09
2 Research 10 days Wed Jan 28, ‘09 Tues Feb 10, ’09 Writer
Call w/ author and create Author/Writer
3 5 days Wed Feb 11, ‘09 Tues Feb 17, ’09
outline
4 Expanded outline to client 15 days Wed Feb 18, ’09 Tues Mar 10, ’09 Writer
5 Client comments on outline 10 days Wed Mar 11, ’09 Tues Mar 24, ’09 Client
6 Expanded outline to authors 10 days Wed Mar 25, ’09 Tues April 7, ’09 Writer
7 Authors comments to ABC 10 days Wed April 8, ’09 Tues April 21, ’09 Author
Client comments on 1st draft to Client
8 5 days Wed April 22, ’09 Tues April 28, ’09
ABC
9 Draft 1 to author 10 days Wed April 29, ’09 Tues May 12, ’09 Writer
10 Author review of Draft 1 10 days Wed May 13, ’09 Tues May 26, ’09 Author
11 Draft 2 to authors and Client 5 days Wed May 27, ’09 Tues Jun 2, ‘09 Writer
Client/
12 All comments due to ABC 5 days Wed Jun 3, ’09 Tues Jun 9, ‘09 Author
Final draft to authors and
13 5 days Wed Jun 10, ’09 Tues Jun 16, ‘09 Writer
Client
All comments and final Client/
14 5 days Wed Jun 17, ’09 Tues Jun 23, ‘09 Author
approval due
15 Writer
Confidential – Not for Distribution day
Submission 1 Wed Jun 24, ‘09 Wed Jun 24, ‘09
18. Objectives Strategy
Measurement Audience
Planning & Measurement Execution Messages
Channels
Project Estimated
Project # Start Status Variance Comments
Name Finish
ADV01 Case Study 12/27/09 3/13/10 On Track Waiting for data
Awaiting data from
ADV02 Abstract PKPD 11/23/09 1/10/10 +10 days
Clinical
Faculty presentation
ADV03 Symposia 12/3/09 5/9/10 +5 days
catch up plan in place
Primary On target for first
ADV04 12/6/09 6/20/10 On Track
Manuscript draft
ADV05 Ad Board 3/16/10 10/23/10 On Track Creating advisor list
On Track Caution Off Track
Variance +/- 5 days Variance 5-10 days off Variance + 10 days
Confidential – Not for Distribution
19. Publication Powerhouse
AlphaBioCom broadest
publication experience
• Published in over 100
journals
• Across 20 different
therapeutic categories
• Spanning US, Eu and
International journals
• Working with more 500
authors
• Located in 10 different
countries
• Yet we demand that every
single paper receives the
same precision, integrity and
passion as our first!
20. Clients Clients
Our ….Partners
Confidential – Not for Distribution
21. Precision, Integrity and Passion in our 7th year
Scientific • 19 plans
Communication Plans
Scientific • >250 scientific manuscripts
Communication • >100 congress submissions (abstracts, posters)
Deliverables • >200 scientific presentations
• 70 advisory boards
TL/KOL • 25 TL education programs
22. Performance Indicators:
Precision, Integrity and Passion in numbers.
Scientific • 100% approved and implemented
Communication Plans
• >90% acceptance first journal
Scientific submitted
Communication
• 100% all journal submissions
Deliverables
• >98% acceptance first congress
23. Power in the Negative
• Zero manuscripts rejected due to poor quality
writing
• Never cited for inaccuracies or data
management error by any client
• Never cited for a process compliance issue by
any client
• Never had to withdraw any deliverable due to
error
• Never failed a client audit
• Zero citations in any newspaper
• Evidence our processes are robust and work
24. Contact Information
Stephen Douthwaite
President and Chief Strategist
2 Radnor Corporate Center, Suite 200
100 Matsonford Road
Radnor, PA 19087
(610) 225-0400
stephend@alphabiocom.com
Confidential – Not for Distribution
